ASYMPTOTE GENETIC MEDICINES Trademark

Trademark Overview


On Friday, December 20, 2024, a trademark application was filed for ASYMPTOTE GENETIC MEDICINES with the United States Patent and Trademark Office. The USPTO has given the ASYMPTOTE GENETIC MEDICINES trademark a serial number of 98915361. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, June 10, 2025. This trademark is owned by Asymptote Genetic Medicines, Inc.. The ASYMPTOTE GENETIC MEDICINES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biological research; Biological research and analysis; Development of gene-based medicines; Gene therapy research; Laboratory research services in the field of gene expression; Medical research; Medical research services; Research in the field of gene editing technology; Research in the field of synthetic biology; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for engaging in biological, medical, and gene therapy research; Software as a service (SAAS) services, namely, hosting software for use by others for engaging in biological, medical, and gene therapy research; Providing laboratory research services in the field of gene expression, namely, cancer biology; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
asymptote genetic medicines

General Information


Serial Number98915361
Word MarkASYMPTOTE GENETIC MEDICINES
Filing DateFriday, December 20, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, June 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBiological research; Biological research and analysis; Development of gene-based medicines; Gene therapy research; Laboratory research services in the field of gene expression; Medical research; Medical research services; Research in the field of gene editing technology; Research in the field of synthetic biology; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for engaging in biological, medical, and gene therapy research; Software as a service (SAAS) services, namely, hosting software for use by others for engaging in biological, medical, and gene therapy research; Providing laboratory research services in the field of gene expression, namely, cancer biology; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 20, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAsymptote Genetic Medicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPasadena, CA 91106

Trademark Events


Event DateEvent Description
Sunday, April 27, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 6, 2025ASSIGNED TO EXAMINER
Tuesday, June 10, 2025NON-FINAL ACTION E-MAILED
Tuesday, June 10, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 10, 2025NON-FINAL ACTION WRITTEN
Friday, December 20, 2024NEW APPLICATION ENTERED